Human Recombinant Insulin Market to Soar with Innovative Bioreactor Technologies
Human recombinant insulin, produced via advanced genetic engineering and fermentation processes, serves as a cornerstone therapy for managing type 1 and type 2 diabetes. By leveraging recombinant DNA technology, manufacturers can create insulin analogs that mimic natural human insulin more precisely, reducing the risk of hypoglycemia and improving